Oncolytic Virus Immunotherapy Market Report by Virus Type (Herpes Simplex Virus, Adenovirus, Vaccinia Virus, Newcastle Disease Virus, Reovirus, and Others), Application (Melanoma, Breast Cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer, Myeloma, Bladder Cancer, Colorectal Cancer, and Others), End-User (Hospitals & Clinics, Cancer Research Institutes, Ambulatory Surgical Centers, and Others), Route of Administration (Intratumoral, Intravenous, and Others), Region and Competitive Landscape (Market Share, Business Overview, Products Offered, Business Strategies, SWOT Analysis and Major News and Events) 2024-2032

Oncolytic Virus Immunotherapy Market Report by Virus Type (Herpes Simplex Virus, Adenovirus, Vaccinia Virus, Newcastle Disease Virus, Reovirus, and Others), Application (Melanoma, Breast Cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer, Myeloma, Bladder Cancer, Colorectal Cancer, and Others), End-User (Hospitals & Clinics, Cancer Research Institutes, Ambulatory Surgical Centers, and Others), Route of Administration (Intratumoral, Intravenous, and Others), Region and Competitive Landscape (Market Share, Business Overview, Products Offered, Business Strategies, SWOT Analysis and Major News and Events) 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A23130
Buy Now

1    Preface
2    Scope and Methodology

2.1    Objectives of the Study
2.2.    Stakeholders
2.3.    Data Sources
2.3.1.    Primary Sources
2.3.2.    Secondary Sources
2.4.    Market Estimation
2.4.1.    Bottom-Up Approach
2.4.2.    Top-Down Approach
2.5.    Forecasting Methodology
3.    Executive Summary
4.    Global Oncolytic Virus Immunotherapy Market – Introduction

4.1.    What is Oncolytic Virus Immunotherapy
4.1.1.    Introduction
4.1.2.    Major Applications
4.2.    Industry Trends
4.3.    Competitive Intelligence
5.    Global Oncolytic Virus Immunotherapy Market Landscape
5.1.    Historical and Current Market Trends (2018-2023)
5.2.    Market Forecast (2024-2032)
6.    Global Oncolytic Virus Immunotherapy Market - Breakup by Virus Type
6.1.        Herpes Simplex Virus (HSV)
6.1.1.    Overview
6.1.2.    Historical and Current Market Trends (2018-2023)
6.1.3.    Market Forecast (2024-2032)
6.1.4.    Market Breakup by Application 
6.1.5.    Market Breakup by Route of Administration
6.1.6.    Market Breakup by End-User 
6.1.7.    Key Players 
6.2.        Adenovirus
6.2.1.    Overview
6.2.2.    Historical and Current Market Trends (2018-2023)
6.2.3.    Market Forecast (2024-2032)
6.2.4.    Market Breakup by Application 
6.2.5.    Market Breakup by Route of Administration
6.2.6.    Market Breakup by End-User 
6.2.7.    Key Players 
6.3.        Vaccinia Virus
6.3.1.    Overview
6.3.2.    Historical and Current Market Trends (2018-2023)
6.3.3.    Market Forecast (2024-2032)
6.3.4.    Market Breakup by Application 
6.3.5.    Market Breakup by Route of Administration
6.3.6.    Market Breakup by End-User 
6.3.7.    Key Players 
6.4.        Newcastle Disease Virus
6.4.1.    Overview
6.4.2.    Historical and Current Market Trends (2018-2023)
6.4.3.    Market Forecast (2024-2032)
6.4.4.    Market Breakup by Application 
6.4.5.    Market Breakup by Route of Administration
6.4.6.    Market Breakup by End-User 
6.4.7.    Key Players 
6.5.        Reovirus
6.5.1.    Overview
6.5.2.    Historical and Current Market Trends (2018-2023)
6.5.3.    Market Forecast (2024-2032)
6.5.4.    Market Breakup by Application 
6.5.5.    Market Breakup by Route of Administration
6.5.6.    Market Breakup by End-User 
6.5.7.    Key Players 
6.6.        Others
6.6.1.    Overview
6.6.2.    Historical and Current Market Trends (2018-2023)
6.6.3.    Market Forecast (2024-2032)
6.6.4.    Market Breakup by Application 
6.6.5.    Market Breakup by Route of Administration
6.6.6.    Market Breakup by End-User 
6.6.7.    Key Players 
6.7.    Attractive Investment Proposition by Virus Type
7.    Global Oncolytic Virus Immunotherapy Market - Breakup by Application
7.1.        Melanoma
7.1.1.    Overview
7.1.2.    Historical and Current Market Trends (2018-2023)
7.1.3.    Market Forecast (2024-2032)
7.1.4.    Market Breakup by Route of Administration 
7.1.5.    Market Breakup by Virus Type
7.1.6.    Market Breakup by End-User 
7.1.7.    Key Players 
7.2.        Breast Cancer
7.2.1.    Overview
7.2.2.    Historical and Current Market Trends (2018-2023)
7.2.3.    Market Forecast (2024-2032)
7.2.4.    Market Breakup by Route of Administration 
7.2.5.    Market Breakup by Virus Type
7.2.6.    Market Breakup by End-User 
7.2.7.    Key Players 
7.3.        Lung Cancer
7.3.1.    Overview
7.3.2.    Historical and Current Market Trends (2018-2023)
7.3.3.    Market Forecast (2024-2032)
7.3.4.    Market Breakup by Route of Administration 
7.3.5.    Market Breakup by Virus Type
7.3.6.    Market Breakup by End-User 
7.3.7.    Key Players 
7.4.        Ovarian Cancer
7.4.1.    Overview
7.4.2.    Historical and Current Market Trends (2018-2023)
7.4.3.    Market Forecast (2024-2032)
7.4.4.    Market Breakup by Route of Administration 
7.4.5.    Market Breakup by Virus Type
7.4.6.    Market Breakup by End-User 
7.4.7.    Key Players 
7.5.        Prostate Cancer
7.5.1.    Overview
7.5.2.    Historical and Current Market Trends (2018-2023)
7.5.3.    Market Forecast (2024-2032)
7.5.4.    Market Breakup by Route of Administration 
7.5.5.    Market Breakup by Virus Type
7.5.6.    Market Breakup by End-User 
7.5.7.    Key Players 
7.6.        Myeloma
7.6.1.    Overview
7.6.2.    Historical and Current Market Trends (2018-2023)
7.6.3.    Market Forecast (2024-2032)
7.6.4.    Market Breakup by Route of Administration 
7.6.5.    Market Breakup by Virus Type
7.6.6.    Market Breakup by End-User 
7.6.7.    Key Players 
7.7.        Bladder Cancer
7.7.1.    Overview
7.7.2.    Historical and Current Market Trends (2018-2023)
7.7.3.    Market Forecast (2024-2032)
7.7.4.    Market Breakup by Route of Administration 
7.7.5.    Market Breakup by Virus Type
7.7.6.    Market Breakup by End-User 
7.7.7.    Key Players 
7.8.    Colorectal Cancer
7.8.1.    Overview
7.8.2.    Historical and Current Market Trends (2018-2023)
7.8.3.    Market Forecast (2024-2032)
7.8.4.    Market Breakup by Route of Administration 
7.8.5.    Market Breakup by Virus Type
7.8.6.    Market Breakup by End-User 
7.8.7.    Key Players 
7.9.        Others
7.9.1.    Overview
7.9.2.    Historical and Current Market Trends (2018-2023)
7.9.3.    Market Forecast (2024-2032)
7.9.4.    Market Breakup by Route of Administration 
7.9.5.    Market Breakup by Virus Type
7.9.6.    Market Breakup by End-User 
7.9.7.    Key Players 
7.10.    Attractive Investment Proposition by Application
8.    Global Oncolytic Virus Immunotherapy Market - Breakup by End-User
8.1.        Hospitals & Clinics
8.1.1.    Overview
8.1.2.    Historical and Current Market Trends (2018-2023)
8.1.3.    Market Forecast (2024-2032)
8.1.4.    Market Breakup by Route of Administration 
8.1.5.    Market Breakup by Virus Type
8.1.6.    Market Breakup by Application
8.1.7.    Key Players 
8.2.        Cancer Research Institutes
8.2.1.    Overview
8.2.2.    Historical and Current Market Trends (2018-2023)
8.2.3.    Market Forecast (2024-2032)
8.2.4.    Market Breakup by Route of Administration 
8.2.5.    Market Breakup by Virus Type
8.2.6.    Market Breakup by Application
8.2.7.    Key Players 
8.3.        Ambulatory Surgical Centers
8.3.1.    Overview
8.3.2.    Historical and Current Market Trends (2018-2023)
8.3.3.    Market Forecast (2024-2032)
8.3.4.    Market Breakup by Route of Administration 
8.3.5.    Market Breakup by Virus Type
8.3.6.    Market Breakup by Application
8.3.7.    Key Players 
8.4.        Others
8.4.1.    Overview
8.4.2.    Historical and Current Market Trends (2018-2023)
8.4.3.    Market Forecast (2024-2032)
8.4.4.    Market Breakup by Route of Administration 
8.4.5.    Market Breakup by Virus Type
8.4.6.    Market Breakup by Application
8.4.7.    Key Players 
8.5.    Attractive Investment Proposition by End-User
9.    Global Oncolytic Virus Immunotherapy Market - Breakup by Route of Administration
9.1.        Intratumoral
9.1.1.    Overview
9.1.2.    Historical and Current Market Trends (2018-2023)
9.1.3.    Market Forecast (2024-2032)
9.1.4.    Market Breakup by End-User
9.1.5.    Market Breakup by Virus Type
9.1.6.    Market Breakup by Application
9.1.7.    Key Players
9.2.        Intravenous
9.2.1.    Overview
9.2.2.    Historical and Current Market Trends (2018-2023)
9.2.3.    Market Forecast (2024-2032)
9.2.4.    Market Breakup by End-User
9.2.5.    Market Breakup by Virus Type
9.2.6.    Market Breakup by Application
9.2.7.    Key Players
9.3.        Others
9.3.1.    Overview
9.3.2.    Historical and Current Market Trends (2018-2023)
9.3.3.    Market Forecast (2024-2032)
9.3.4.    Market Breakup by End-User
9.3.5.    Market Breakup by Virus Type
9.3.6.    Market Breakup by Application
9.3.7.    Key Players
9.4.    Attractive Investment Proposition by Route of Administration
10.    Global Oncolytic Virus Immunotherapy Market – Breakup by Region
10.1.    North America
10.1.1.        United States
10.1.1.1.    Market Drivers
10.1.1.2.    Historical and Current Market Trends (2018-2023)
10.1.1.3.    Market Breakup by Virus Type
10.1.1.4.    Market Breakup by Application
10.1.1.5.    Market Breakup by End-User
10.1.1.6.    Market Breakup by Route of Administration
10.1.1.7.    Key Players
10.1.1.8.    Market Forecast (2024-2032)
10.1.1.9.    Recent Investments
10.1.1.9.1.    Government Investments
10.1.1.9.2.    Private Investments
10.1.1.10.    Regulatory Approval Process
10.1.1.11.    Pricing Analysis 
10.1.2.        Canada
10.1.2.1.    Market Drivers
10.1.2.2.    Historical and Current Market Trends (2018-2023)
10.1.2.3.    Market Breakup by Virus Type
10.1.2.4.    Market Breakup by Application
10.1.2.5.    Market Breakup by End-User
10.1.2.6.    Market Breakup by Route of Administration
10.1.2.7.    Key Players
10.1.2.8.    Market Forecast (2024-2032)
10.1.2.9.    Recent Investments
10.1.2.9.1.    Government Investments
10.1.2.9.2.    Private Investments
10.1.2.10.    Regulatory Approval Process
10.1.2.11.    Pricing Analysis 
10.2.    Europe
10.2.1.        Germany
10.2.1.1.    Market Drivers
10.2.1.2.    Historical and Current Market Trends (2018-2023)
10.2.1.3.    Market Breakup by Virus Type
10.2.1.4.    Market Breakup by Application
10.2.1.5.    Market Breakup by End-User
10.2.1.6.    Market Breakup by Route of Administration
10.2.1.7.    Key Players
10.2.1.8.    Market Forecast (2024-2032)
10.2.1.9.    Recent Investments
10.2.1.9.1.    Government Investments
10.2.1.9.2.    Private Investments
10.2.1.10.    Regulatory Approval Process
10.2.1.11.    Pricing Analysis 
10.2.2.        France
10.2.2.1.    Market Drivers
10.2.2.2.    Historical and Current Market Trends (2018-2023)
10.2.2.3.    Market Breakup by Virus Type
10.2.2.4.    Market Breakup by Application
10.2.2.5.    Market Breakup by End-User
10.2.2.6.    Market Breakup by Route of Administration
10.2.2.7.    Key Players
10.2.2.8.    Market Forecast (2024-2032)
10.2.2.9.    Recent Investments
10.2.2.9.1.    Government Investments
10.2.2.9.2.    Private Investments
10.2.2.10.    Regulatory Approval Process
10.2.2.11.    Pricing Analysis 
10.2.3.        United Kingdom
10.2.3.1.    Market Drivers
10.2.3.2.    Historical and Current Market Trends (2018-2023)
10.2.3.3.    Market Breakup by Virus Type
10.2.3.4.    Market Breakup by Application
10.2.3.5.    Market Breakup by End-User
10.2.3.6.    Market Breakup by Route of Administration
10.2.3.7.    Key Players
10.2.3.8.    Market Forecast (2024-2032)
10.2.3.9.    Recent Investments
10.2.3.9.1.    Government Investments
10.2.3.9.2.    Private Investments
10.2.3.10.    Regulatory Approval Process
10.2.3.11.    Pricing Analysis 
10.2.4.        Italy
10.2.4.1.    Market Drivers
10.2.4.2.    Historical and Current Market Trends (2018-2023)
10.2.4.3.    Market Breakup by Virus Type
10.2.4.4.    Market Breakup by Application
10.2.4.5.    Market Breakup by End-User
10.2.4.6.    Market Breakup by Route of Administration
10.2.4.7.    Key Players
10.2.4.8.    Market Forecast (2024-2032)
10.2.4.9.    Recent Investments
10.2.4.9.1.    Government Investments
10.2.4.9.2.    Private Investments
10.2.4.10.    Regulatory Approval Process
10.2.4.11.    Pricing Analysis 
10.2.5.        Spain
10.2.5.1.    Market Drivers
10.2.5.2.    Historical and Current Market Trends (2018-2023)
10.2.5.3.    Market Breakup by Virus Type
10.2.5.4.    Market Breakup by Application
10.2.5.5.    Market Breakup by End-User
10.2.5.6.    Market Breakup by Route of Administration
10.2.5.7.    Key Players
10.2.5.8.    Market Forecast (2024-2032)
10.2.5.9.    Recent Investments
10.2.5.9.1.    Government Investments
10.2.5.9.2.    Private Investments
10.2.5.10.    Regulatory Approval Process
10.2.5.11.    Pricing Analysis 
10.2.6.        Russia
10.2.6.1.    Market Drivers
10.2.6.2.    Historical and Current Market Trends (2018-2023)
10.2.6.3.    Market Breakup by Virus Type
10.2.6.4.    Market Breakup by Application
10.2.6.5.    Market Breakup by End-User
10.2.6.6.    Market Breakup by Route of Administration
10.2.6.7.    Key Players
10.2.6.8.    Market Forecast (2024-2032)
10.2.6.9.    Recent Investments
10.2.6.9.1.    Government Investments
10.2.6.9.2.    Private Investments
10.2.6.10.    Regulatory Approval Process
10.2.6.11.    Pricing Analysis 
10.2.7.        Others
6.7.1.1.    Historical and Current Market Trends (2018-2023)
6.7.1.2.    Market Forecast (2024-2032)
10.3.    Asia Pacific 
10.3.1.        China
10.3.1.1.    Market Drivers
10.3.1.2.    Historical and Current Market Trends (2018-2023)
10.3.1.3.    Market Breakup by Virus Type
10.3.1.4.    Market Breakup by Application
10.3.1.5.    Market Breakup by End-User
10.3.1.6.    Market Breakup by Route of Administration
10.3.1.7.    Key Players
10.3.1.8.    Market Forecast (2024-2032)
10.3.1.9.    Recent Investments
10.3.1.9.1.    Government Investments
10.3.1.9.2.    Private Investments
10.3.1.10.    Regulatory Approval Process
10.3.1.11.    Pricing Analysis 
10.3.2.        Japan
10.3.2.1.    Market Drivers
10.3.2.2.    Historical and Current Market Trends (2018-2023)
10.3.2.3.    Market Breakup by Virus Type
10.3.2.4.    Market Breakup by Application
10.3.2.5.    Market Breakup by End-User
10.3.2.6.    Market Breakup by Route of Administration
10.3.2.7.    Key Players
10.3.2.8.    Market Forecast (2024-2032)
10.3.2.9.    Recent Investments
10.3.2.9.1.    Government Investments
10.3.2.9.2.    Private Investments
10.3.2.10.    Regulatory Approval Process
10.3.2.11.    Pricing Analysis 
10.3.3.        India
10.3.3.1.    Market Drivers
10.3.3.2.    Historical and Current Market Trends (2018-2023)
10.3.3.3.    Market Breakup by Virus Type
10.3.3.4.    Market Breakup by Application
10.3.3.5.    Market Breakup by End-User
10.3.3.6.    Market Breakup by Route of Administration
10.3.3.7.    Key Players
10.3.3.8.    Market Forecast (2024-2032)
10.3.3.9.    Recent Investments
10.3.3.9.1.    Government Investments
10.3.3.9.2.    Private Investments
10.3.3.10.    Regulatory Approval Process
10.3.3.11.    Pricing Analysis 
10.3.4.        South Korea
10.3.4.1.    Market Drivers
10.3.4.2.    Historical and Current Market Trends (2018-2023)
10.3.4.3.    Market Breakup by Virus Type
10.3.4.4.    Market Breakup by Application
10.3.4.5.    Market Breakup by End-User
10.3.4.6.    Market Breakup by Route of Administration
10.3.4.7.    Key Players
10.3.4.8.    Market Forecast (2024-2032)
10.3.4.9.    Recent Investments
10.3.4.9.1.    Government Investments
10.3.4.9.2.    Private Investments
10.3.4.10.    Regulatory Approval Process
10.3.4.11.    Pricing Analysis 
10.3.5.        Australia
10.3.5.1.    Market Drivers
10.3.5.2.    Historical and Current Market Trends (2018-2023)
10.3.5.3.    Market Breakup by Virus Type
10.3.5.4.    Market Breakup by Application
10.3.5.5.    Market Breakup by End-User
10.3.5.6.    Market Breakup by Route of Administration
10.3.5.7.    Key Players
10.3.5.8.    Market Forecast (2024-2032)
10.3.5.9.    Recent Investments
10.3.5.9.1.    Government Investments
10.3.5.9.2.    Private Investments
10.3.5.10.    Regulatory Approval Process
10.3.5.11.    Pricing Analysis 
10.3.6.        Indonesia
10.3.6.1.    Market Drivers
10.3.6.2.    Historical and Current Market Trends (2018-2023)
10.3.6.3.    Market Breakup by Virus Type
10.3.6.4.    Market Breakup by Application
10.3.6.5.    Market Breakup by End-User
10.3.6.6.    Market Breakup by Route of Administration
10.3.6.7.    Key Players
10.3.6.8.    Market Forecast (2024-2032)
10.3.6.9.    Recent Investments
10.3.6.9.1.    Government Investments
10.3.6.9.2.    Private Investments
10.3.6.10.    Regulatory Approval Process
10.3.6.11.    Pricing Analysis 
10.3.7.        Others
10.3.7.1.    Historical and Current Market Trends (2018-2023)
10.3.7.2.    Market Forecast (2024-2032)
10.4.    Latin America
10.4.1.        Brazil
10.4.1.1.    Market Drivers
10.4.1.2.    Historical and Current Market Trends (2018-2023)
10.4.1.3.    Market Breakup by Virus Type
10.4.1.4.    Market Breakup by Application
10.4.1.5.    Market Breakup by End-User
10.4.1.6.    Market Breakup by Route of Administration
10.4.1.7.    Key Players
10.4.1.8.    Market Forecast (2024-2032)
10.4.1.9.    Recent Investments
10.4.1.9.1.    Government Investments
10.4.1.9.2.    Private Investments
10.4.1.10.    Regulatory Approval Process
10.4.1.11.    Pricing Analysis 
10.4.2.        Mexico
10.4.2.1.    Market Drivers
10.4.2.2.    Historical and Current Market Trends (2018-2023)
10.4.2.3.    Market Breakup by Virus Type
10.4.2.4.    Market Breakup by Application
10.4.2.5.    Market Breakup by End-User
10.4.2.6.    Market Breakup by Route of Administration
10.4.2.7.    Key Players
10.4.2.8.    Market Forecast (2024-2032)
10.4.2.9.    Recent Investments
10.4.2.9.1.    Government Investments
10.4.2.9.2.    Private Investments
10.4.2.10.    Regulatory Approval Process
10.4.2.11.    Pricing Analysis 
10.4.3.        Others
10.4.3.1.    Historical and Current Market Trends (2018-2023)
10.4.3.2.    Market Forecast (2024-2032)
10.5.    Middle East
10.5.1.    Market Drivers
10.5.2.    Historical and Current Market Trends (2018-2023)
10.5.3.    Market Breakup by Virus Type
10.5.4.    Market Breakup by Application
10.5.5.    Market Breakup by End-User
10.5.6.    Market Breakup by Route of Administration
10.5.7.    Market Breakup by Country
10.5.8.    Key Players
10.5.9.    Market Forecast (2024-2032)
10.5.10.    Recent Investments
10.5.10.1.    Government Investments
10.5.10.2.    Private Investments
10.5.11.    Regulatory Approval Process
10.5.12.    Pricing Analysis
10.6.    Africa
10.6.1.    Market Drivers
10.6.2.    Historical and Current Market Trends (2018-2023)
10.6.3.    Market Breakup by Virus Type
10.6.4.    Market Breakup by Application
10.6.5.    Market Breakup by End-User
10.6.6.    Market Breakup by Route of Administration
10.6.7.    Market Breakup by Country
10.6.8.    Key Players
10.6.9.    Market Forecast (2024-2032)
10.6.10.    Recent Investments
10.6.10.1.    Government Investments
10.6.10.2.    Private Investments
10.6.11.    Regulatory Approval Process
10.6.12.    Pricing Analysis
10.7.    Attractive Investment Proposition by Region
11.    Technology Analysis 
11.1.    Overview of Different Technologies
11.2.    Technology wise Oncolytic Virus Immunotherapy Applications
11.3.    Time to Market for New Product
11.4.    Key Technology Trends
11.4.1.    Engineering of Oncolytic Viruses
11.4.2.     Biomarker Identification
11.4.3.    Combination Therapies
12.    Government Regulations and Strategies
13.    Global Oncolytic Virus Immunotherapy Market - Industry Analysis

13.1.    Drivers, Restraints, and Opportunities
13.1.1.    Overview
13.1.2.    Drivers
13.1.2.1.    Limitations of Traditional Therapies
13.1.2.2.    Rising Investments in R&D
13.1.2.3.    Technological Advancements
13.1.3.    Restraints
13.1.3.1.    Limited Understanding of Mechanisms
13.1.3.2.    Manufacturing Challenges
13.1.3.3.    Regulatory Hurdles
13.1.4.    Opportunities
13.1.4.1.    Market Expansion in Emerging Economies
13.1.4.2.    Expanded Clinical Trials
13.1.5.    Impact Analysis
13.2.    Porters Five Forces Analysis
13.2.1.    Overview
13.2.2.    Bargaining Power of Buyers
13.2.3.    Bargaining Power of Suppliers
13.2.4.    Degree of Competition
13.2.5.    Threat of New Entrants
13.2.6.    Threat of Substitutes
13.3.    Value Chain Analysis
14.    Global Oncolytic Virus Immunotherapy Market – Competitive Landscape
14.1.    Overview
14.2.    Market Structure
14.3.    Market Share by Key Players
14.4.    Market Player Positioning
14.5.    Top Winning Strategies
14.6.    Competitive Dashboard
14.7.    Company Evaluation Quadrant
15.    Profiles of Key Players
15.1.    Amgen Inc.
15.1.1.    Business Overview
15.1.2.    Products Offered
15.1.3.    Business Strategies
15.1.3.1.    Marketing Strategy
15.1.3.2.    Product Strategy
15.1.3.3.    Channel Strategy
15.1.4.    SWOT Analysis
15.1.5.    Major News and Events
15.2.    Creative Biolabs 
15.2.1.    Business Overview
15.2.2.    Products Offered
15.2.3.    Business Strategies
15.2.3.1.    Marketing Strategy
15.2.3.2.    Product Strategy
15.2.3.3.    Channel Strategy
15.2.4.    SWOT Analysis
15.2.5.    Major News and Events
15.3.    Daiichi Sankyo Company Limited
15.3.1.    Business Overview
15.3.2.    Products Offered
15.3.3.    Business Strategies
15.3.3.1.    Marketing Strategy
15.3.3.2.    Product Strategy
15.3.3.3.    Channel Strategy
15.3.4.    SWOT Analysis
15.3.5.    Major News and Events
15.4.    Genelux Corporation
15.4.1.    Business Overview
15.4.2.    Products Offered
15.4.3.    Business Strategies
15.4.3.1.    Marketing Strategy
15.4.3.2.    Product Strategy
15.4.3.3.    Channel Strategy
15.4.4.    Financials
15.4.5.    SWOT Analysis
15.4.6.    Major News and Events
15.5.    Oncorus Inc.
15.5.1.    Business Overview
15.5.2.    Products Offered
15.5.3.    Business Strategies
15.5.3.1.    Marketing Strategy
15.5.3.2.    Product Strategy
15.5.3.3.    Channel Strategy
15.5.4.    SWOT Analysis
15.5.5.    Major News and Events
15.6.    Replismune Inc.
15.6.1.    Business Overview
15.6.2.    Products Offered
15.6.3.    Business Strategies
15.6.3.1.    Marketing Strategy
15.6.3.2.    Product Strategy
15.6.3.3.    Channel Strategy
15.6.4.    SWOT Analysis
15.6.5.    Major News and Events
15.7.    Siga Technologies
15.7.1.    Business Overview
15.7.2.    Products Offered
15.7.3.    Business Strategies
15.7.3.1.    Marketing Strategy
15.7.3.2.    Product Strategy
15.7.3.3.    Channel Strategy
15.7.4.    SWOT Analysis
15.7.5.    Major News and Events
15.8.    Sorrento Therapeutics Inc.
15.8.1.    Business Overview
15.8.2.    Products Offered
15.8.3.    Business Strategies
15.8.3.1.    Marketing Strategy
15.8.3.2.    Product Strategy
15.8.3.3.    Channel Strategy
15.8.4.    Financials
15.8.5.    SWOT Analysis
15.8.6.    Major News and Events
15.9.    TILT Biotherapeutics
15.9.1.    Business Overview
15.9.2.    Products Offered
15.9.3.    Business Strategies
15.9.3.1.    Marketing Strategy
15.9.3.2.    Product Strategy
15.9.3.3.    Channel Strategy
15.9.4.    SWOT Analysis
15.9.5.    Major News and Events
15.10.    Viralytics Ltd.
15.10.1.    Business Overview
15.10.2.    Products Offered
15.10.3.    Business Strategies
15.10.3.1.    Marketing Strategy
15.10.3.2.    Product Strategy
15.10.3.3.    Channel Strategy
15.10.4.    SWOT Analysis
15.10.5.    Major News and Events
  
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

16.    Strategic Recommendations
17.    Appendix

Oncolytic Virus Immunotherapy Market Report by Virus Type (Herpes Simplex Virus, Adenovirus, Vaccinia Virus, Newcastle Disease Virus, Reovirus, and Others), Application (Melanoma, Breast Cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer, Myeloma, Bladder Cancer, Colorectal Cancer, and Others), End-User (Hospitals & Clinics, Cancer Research Institutes, Ambulatory Surgical Centers, and Others), Route of Administration (Intratumoral, Intravenous, and Others), Region and Competitive Landscape (Market Share, Business Overview, Products Offered, Business Strategies, SWOT Analysis and Major News and Events) 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More